| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,098 | 14,392 | 14,919 | 15,192 | | Cost of Revenue | 3,802 | 3,781 | 3,623 | 3,846 | | | Gross Profit |
-
| 10,611 | 11,296 | 11,346 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,607 | 7,465 | 7,233 | 6,587 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,899 | 6,788 | 2,098 | 1,021 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (3,642) | 1,965 | 3,738 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,604) | (3,642) | 1,965 | 3,738 | | Interest Expense | 1,287 | 1,201 | 1,324 | 1,405 | | Income Before Tax | (2,752) | (4,843) | 641 | 2,333 | | Income Tax Expense | (674) | (2,001) | 201 | 824 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,078) | (2,842) | 440 | 1,509 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,078) | (2,842) | 440 | 1,509 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,078) | ($2,842) | $440 | $1,509 |
|
1.52% Nasdaq 0.00%
Income Statement
